Thrombocytopenia

Bleeding Events Before vs After Lowering Departmental Platelet Transfusion Trigger

Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transfusion

177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia

Managed Access Programs for ETB115, Eltrombopag

Apixaban in Thrombocytopenia

Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma

Neonatal Platelet Transfusion Threshold Trial

Luspatercept for Clonal Cytopenias of Uncertain Significance

Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT)

A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients

Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT

Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis

STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis

Bioequivalence Study of Eltrombopag Olamine Tablets in Healthy Subjects in the Fed State

Herombopag Treated T-DM1 Induced Platelet Reduction

Platelet-Directed Whole Blood Transfusion Strategy for Malaria

A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors

The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)

Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for Cancer Therapy-Induced Thrombocytopenia (CTIT)

Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia